PE20141199A1 - Depsipeptidos ciclicos como moduladores de calicreina 7 - Google Patents
Depsipeptidos ciclicos como moduladores de calicreina 7Info
- Publication number
- PE20141199A1 PE20141199A1 PE2014000462A PE2014000462A PE20141199A1 PE 20141199 A1 PE20141199 A1 PE 20141199A1 PE 2014000462 A PE2014000462 A PE 2014000462A PE 2014000462 A PE2014000462 A PE 2014000462A PE 20141199 A1 PE20141199 A1 PE 20141199A1
- Authority
- PE
- Peru
- Prior art keywords
- calicrein
- modulators
- amino acid
- side chain
- depsipeptides
- Prior art date
Links
- 108010002156 Depsipeptides Proteins 0.000 title abstract 3
- 229940024606 amino acid Drugs 0.000 abstract 3
- 235000001014 amino acid Nutrition 0.000 abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 2
- 229960000310 isoleucine Drugs 0.000 abstract 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- 241000862992 Chondromyces Species 0.000 abstract 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000013922 glutamic acid Nutrition 0.000 abstract 1
- 239000004220 glutamic acid Substances 0.000 abstract 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
- 230000003463 hyperproliferative effect Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A DEPSIPEPTIDOS CICLICOS DE FORMULA (I') DONDE X ES H, UN RESIDUO ACILO, ENTRE OTROS; A1 ES GLUTAMINA, ACIDO GLUTAMICO, ENTRE OTROS; R2 ES H O METILO; R3 ES LA CADENA LATERAL DE UN AMINOACIDO NO BASICO; R5 ES LA CADENA LATERAL DEL AMINOACIDO ISOLEUCINA O VALINA; R6 ES LA CADENA LATERAL DE TIROSINA; R7 ES LA CADENA LATERAL DEL AMINOACIDO LEUCINA, ISOLEUCINA O VALINA; Y ES H O METILO. SON COMPUESTOS PREFERIDOS LOS DE FORMULA (II), (III), ENTRE OTROS. DICHOS DEPSIPEPTIDOS PRODUCIDOS POR CHONDROMYCES SON MODULADORES DE LA CALICREINA 7 SIENDO UTILES EN EL TRATAMIENTO DE CANCER, ENFERMEDADES INFLAMATORIAS, HIPERPROLIFERATIVAS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114507 | 2007-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20141199A1 true PE20141199A1 (es) | 2014-09-24 |
Family
ID=38805728
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2014000462A PE20141199A1 (es) | 2007-08-17 | 2008-08-15 | Depsipeptidos ciclicos como moduladores de calicreina 7 |
| PE2008001396A PE20091007A1 (es) | 2007-08-17 | 2008-08-15 | Depsipeptidos ciclicos como moduladores de calicreina 7 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001396A PE20091007A1 (es) | 2007-08-17 | 2008-08-15 | Depsipeptidos ciclicos como moduladores de calicreina 7 |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US8178650B2 (es) |
| EP (1) | EP2183273B1 (es) |
| JP (1) | JP5520824B2 (es) |
| KR (2) | KR20120123579A (es) |
| CN (1) | CN103298827B (es) |
| AR (1) | AR068343A1 (es) |
| AU (1) | AU2008290567B2 (es) |
| BR (1) | BRPI0815547B8 (es) |
| CA (1) | CA2696570C (es) |
| CL (1) | CL2008002394A1 (es) |
| CO (1) | CO6260099A2 (es) |
| CR (1) | CR11251A (es) |
| CU (2) | CU23943B1 (es) |
| EA (1) | EA017735B1 (es) |
| EC (1) | ECSP109968A (es) |
| ES (1) | ES2632392T3 (es) |
| GT (1) | GT201000037A (es) |
| MA (1) | MA31701B1 (es) |
| MX (1) | MX2010001849A (es) |
| MY (1) | MY151973A (es) |
| NZ (1) | NZ583284A (es) |
| PE (2) | PE20141199A1 (es) |
| PL (1) | PL2183273T3 (es) |
| PT (1) | PT2183273T (es) |
| SV (1) | SV2010003485A (es) |
| TN (1) | TN2010000074A1 (es) |
| TW (1) | TW200922613A (es) |
| UA (1) | UA98658C2 (es) |
| WO (1) | WO2009024527A1 (es) |
| ZA (1) | ZA201000776B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2183273B1 (en) | 2007-08-17 | 2017-04-05 | Novartis AG | Cyclic depsipeptides |
| US8415305B2 (en) | 2007-08-17 | 2013-04-09 | Novartis Ag | Use of cyclic depsipeptides to inhibit kallikrein 7 |
| US20120034650A1 (en) * | 2009-02-13 | 2012-02-09 | Novartis Ag | Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof |
| US8680054B2 (en) * | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
| US8614289B2 (en) * | 2011-04-20 | 2013-12-24 | Novartis Ag | Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US8987413B2 (en) * | 2012-10-09 | 2015-03-24 | Novartis Ag | Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| WO2015112079A1 (en) | 2014-01-23 | 2015-07-30 | Sixera Pharma Ab | New kallikrein 7 inhibitors |
| WO2015114144A1 (en) * | 2014-02-03 | 2015-08-06 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of netherton syndrome |
| CN106029684A (zh) | 2014-04-08 | 2016-10-12 | 诺华股份有限公司 | 用于生产大环缩酚酸肽和新中间体的新型缩醛类方法 |
| KR101729848B1 (ko) | 2015-06-30 | 2017-04-24 | 영남대학교 산학협력단 | 신규한 해양 바실러스속 균주, 이로부터 분리한 화합물 및 상기 화합물의 약제학적 용도 |
| CN106518880B (zh) * | 2015-11-04 | 2018-10-19 | 衡阳师范学院 | 激肽释放酶7小分子抑制剂及其制备方法与用途 |
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| WO2020018888A1 (en) | 2018-07-20 | 2020-01-23 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3043252C2 (de) | 1980-11-15 | 1982-12-02 | Degussa Ag, 6000 Frankfurt | Cyclische Acetale von N-Acylglutaminsäure -γ- semialdehyden, Verfahren zu deren Herstellung und ihre Verwendung |
| US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| DE4421113A1 (de) * | 1994-06-16 | 1995-12-21 | Biotechnolog Forschung Gmbh | Chondramide, Gewinnungsverfahren, Mittel mit Chondramiden und Mischkultur zur Chondramid-Gewinnung |
| DE19828043A1 (de) | 1998-06-24 | 1999-12-30 | Bayer Ag | Ektoparasitizide Mittel |
| JP2000154198A (ja) | 1998-11-20 | 2000-06-06 | Nisshin Flour Milling Co Ltd | 環状デプシペプチドの固相合成方法及びその中間体 |
| GB0108234D0 (en) | 2001-04-02 | 2001-05-23 | Pharma Mar Sa | Process for producing trunkamide A compounds |
| US20040110228A1 (en) | 2002-04-01 | 2004-06-10 | Mcalpine Shelli R. | Combinatorial organic synthesis of unique biologically active compounds |
| NZ543636A (en) | 2003-06-06 | 2009-07-31 | Arexis Ab | Use of fused heterocyclic compounds as SCCE inhibitors for the treatment of skin conditions or cancer |
| GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| WO2005075667A1 (en) * | 2004-02-03 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7) |
| US20090186042A1 (en) * | 2006-02-27 | 2009-07-23 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Identification and use of novopeptides for the treatment of cancer |
| US8415305B2 (en) | 2007-08-17 | 2013-04-09 | Novartis Ag | Use of cyclic depsipeptides to inhibit kallikrein 7 |
| EP2183273B1 (en) | 2007-08-17 | 2017-04-05 | Novartis AG | Cyclic depsipeptides |
| US20110112121A1 (en) | 2009-07-06 | 2011-05-12 | Joerg Berghausen | Pharmaceutical Compositions and Solid Forms |
| US20120064013A1 (en) | 2010-02-03 | 2012-03-15 | David Marcos | Foamable topical composition |
| KR101004362B1 (ko) | 2010-03-19 | 2010-12-28 | 가톨릭대학교 산학협력단 | 자가 면역 질환 예방 및 치료용 ＴＮＦ－α와 ＴＷＥＡＫ 이중 길항제 |
| US20120064136A1 (en) | 2010-09-10 | 2012-03-15 | Nanobio Corporation | Anti-aging and wrinkle treatment methods using nanoemulsion compositions |
| US8673974B2 (en) | 2010-11-16 | 2014-03-18 | Novartis Ag | Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
| SG193972A1 (en) | 2011-01-24 | 2013-11-29 | Anterios Inc | Nanoparticle compositions, formulations thereof, and uses therefor |
| EP2667854B1 (en) | 2011-01-24 | 2019-01-16 | Anterios, Inc. | Nanoparticle compositions |
| US8614289B2 (en) | 2011-04-20 | 2013-12-24 | Novartis Ag | Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US8680054B2 (en) | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
| US8987413B2 (en) | 2012-10-09 | 2015-03-24 | Novartis Ag | Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
-
2008
- 2008-08-14 EP EP08803036.6A patent/EP2183273B1/en active Active
- 2008-08-14 CA CA2696570A patent/CA2696570C/en active Active
- 2008-08-14 AR ARP080103553A patent/AR068343A1/es unknown
- 2008-08-14 KR KR1020127024969A patent/KR20120123579A/ko not_active Application Discontinuation
- 2008-08-14 ES ES08803036.6T patent/ES2632392T3/es active Active
- 2008-08-14 PL PL08803036T patent/PL2183273T3/pl unknown
- 2008-08-14 CN CN200880112017.9A patent/CN103298827B/zh active Active
- 2008-08-14 UA UAA201001638A patent/UA98658C2/uk unknown
- 2008-08-14 AU AU2008290567A patent/AU2008290567B2/en active Active
- 2008-08-14 WO PCT/EP2008/060689 patent/WO2009024527A1/en active Application Filing
- 2008-08-14 EA EA201000329A patent/EA017735B1/ru not_active IP Right Cessation
- 2008-08-14 JP JP2010520585A patent/JP5520824B2/ja active Active
- 2008-08-14 BR BRPI0815547A patent/BRPI0815547B8/pt not_active IP Right Cessation
- 2008-08-14 CL CL2008002394A patent/CL2008002394A1/es unknown
- 2008-08-14 NZ NZ583284A patent/NZ583284A/en not_active IP Right Cessation
- 2008-08-14 MY MYPI20100520 patent/MY151973A/en unknown
- 2008-08-14 KR KR1020107005806A patent/KR101227231B1/ko active IP Right Grant
- 2008-08-14 PT PT88030366T patent/PT2183273T/pt unknown
- 2008-08-14 MX MX2010001849A patent/MX2010001849A/es active IP Right Grant
- 2008-08-15 PE PE2014000462A patent/PE20141199A1/es not_active Application Discontinuation
- 2008-08-15 PE PE2008001396A patent/PE20091007A1/es not_active Application Discontinuation
- 2008-08-15 TW TW097131312A patent/TW200922613A/zh unknown
- 2008-08-18 US US12/193,338 patent/US8178650B2/en active Active
-
2010
- 2010-02-02 ZA ZA201000776A patent/ZA201000776B/xx unknown
- 2010-02-03 CR CR11251A patent/CR11251A/es unknown
- 2010-02-12 TN TNP2010000074A patent/TN2010000074A1/fr unknown
- 2010-02-15 GT GT201000037A patent/GT201000037A/es unknown
- 2010-02-16 CO CO10017551A patent/CO6260099A2/es active IP Right Grant
- 2010-02-17 SV SV2010003485A patent/SV2010003485A/es not_active Application Discontinuation
- 2010-02-17 EC EC2010009968A patent/ECSP109968A/es unknown
- 2010-02-17 CU CU2010000032A patent/CU23943B1/es active IP Right Grant
- 2010-03-12 MA MA32690A patent/MA31701B1/fr unknown
-
2012
- 2012-02-14 US US13/372,758 patent/US9127044B2/en active Active
-
2013
- 2013-05-02 CU CU2013000063A patent/CU20130063A7/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20141199A1 (es) | Depsipeptidos ciclicos como moduladores de calicreina 7 | |
| CO6311079A2 (es) | Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer | |
| ECSP067120A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
| CO6300954A2 (es) | Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk | |
| EA201100564A1 (ru) | Антипролиферативные соединения | |
| ECSP11010949A (es) | Inhibidores de las enzimas de proteína cinasa activadas por mitógeno p38 | |
| CY1119269T1 (el) | Θεραπεια βλαβων που προκαλουνται απο ιους | |
| CR20110620A (es) | Derivados de n-(hetero)aril-pirrolidina de pirazo-4-il-pirrolo[2,3-d]pirimidinas y pirrol-3-il-pirrolo[2,3-d]pirimidinas como ihnibidores de la quinasa janus | |
| HN2011000341A (es) | Compuestos derivados de sulfonamidas, composiciones farmaceuticos y proceso de preparacion de los mismos | |
| CL2008000670A1 (es) | Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras. | |
| ECSP11011079A (es) | Nuevos compuestos de hidroxiareno. | |
| NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
| CR20110610A (es) | Nuevos derivados de pirimidina y sus usos en el tratamiento del cáncer y otras enfermedades | |
| CR20110230A (es) | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 | |
| EA201000950A1 (ru) | Азолилметилоксираны, их применение, а также содержащие их средства | |
| UY32859A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
| ECSP077360A (es) | Compuestos sulfonamida | |
| CL2009000402A1 (es) | Compuestos derivados de 2-amino-acetamida sustituida; composicion farmaceutica; utiles en el tratamiento de enfermedades pulmonares, enfermedad reumatica, enfermedad autoinmune, entre otras. | |
| EA200801220A1 (ru) | 3-аминоциклопентанекарбоксамиды в качестве модуляторов хемокиновых рецепторов | |
| PA8855001A1 (es) | Monocarbamas | |
| CL2011001427A1 (es) | Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras. | |
| CO6382123A2 (es) | Antagonistas de la via hedgehog de ftalazina disustituida | |
| EA201170294A1 (ru) | Способы лечения реперфузионных повреждений | |
| DK2149609T3 (da) | Forbedret fremgangsmåde til fremstilling af daptomycin | |
| UY29498A1 (es) | Derivados de aminoácidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |